Marta Joanna Podralska

Dr. Marta Joanna Podralska

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2020 in Cancers
Verified
Journal Article
Open access
PDF file
MPMarta Podralska
Marta Podralska
SCSylwia Ciesielska
Sylwia Ciesielska
Joost KluiverJoost Kluiver
Joost Kluiver
Anke Van den BergAnke Van den Berg
Anke Van den Berg
ADAgnieszka Dzikiewicz-Krawczyk
Agnieszka Dzikiewicz-Krawczyk
ISIzabella Slezak-Prochazka
Izabella Slezak-Prochazka
Radiotherapy is a cancer treatment that applies high doses of ionizing radiation to induce cell death, mainly by triggering DNA double-strand breaks. The outcome of radiotherapy greatly depends on radiosensitivity of cancer cells, which is determined by multiple proteins and cellular processes. In this review, we summarize current knowledge on the role of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), in determining the response to radiation. Non-coding RNAs modulate ionizing radiation response by targeting key signaling pathways, including DNA damage repair, apoptosis, glycolysis, cell cycle arrest, and autophagy. Additionally, we indicate miRNAs and lncRNAs that upon overexpression or inhibition alter cellular radiosensitivity. Current data indicate the potential of using specific non-coding RNAs as modulators of cellular radiosensitivity to improve outcome of radiotherapy.

27 July 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
ZMZofia E. Madeja
Zofia E. Madeja
MPMarta Podralska
Marta Podralska
ANAgnieszka Nadel
Agnieszka Nadel
MPMarcin Pszczoła
Marcin Pszczoła
PPPiotr Pawlak
Piotr Pawlak
NRNatalia Rozwadowska
Natalia Rozwadowska
Standard sperm evaluation parameters do not enable predicting their ability to survive cryopreservation. Mitochondria are highly prone to suffer injuries during freezing, and any abnormalities in their morphology or function are reflected by a decline of sperm quality. Our work focused on describing a link between the number and the activity of mitochondria, with an aim to validate its applicability as a biomarker of bovine sperm quality. Cryopreserved sperm collected from bulls with high (group 1) and low (group 2) semen quality was separated by swim up. The spermatozoa of group 1 overall retained more mitochondria (MitoTrackerGreen) and mtDNA copies, irrespective of the fraction. Regardless of the initial ejaculate quality, the motile sperm contained significantly more mitochondria and mtDNA copies. The same trend was observed for mitochondrial membrane potential (ΔΨm, JC-1), where motile sperm displayed high ΔΨm. These results stay in agreement with transcript-level evaluation (real-time polymerase chain reaction, PCR) of antioxidant enzymes (PRDX1, SOD1, GSS), which protect cells from the reactive oxygen species. An overall higher level of glutathione synthetase (GSS) mRNA was noted in group 1 bulls, suggesting higher ability to counteract free radicals. No differences were noted between basal oxygen consumption rate (OCR) (Seahorse XF Agilent) and ATP-linked respiration for group 1 and 2 bulls. In conclusion, mitochondrial content and activity may be used as reliable markers for bovine sperm quality evaluation.

1 August 2018 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
MŻMagdalena Żurawek
Magdalena Żurawek
ADAgnieszka Dzikiewicz-Krawczyk
Agnieszka Dzikiewicz-Krawczyk
Katarzyna IżykowskaKatarzyna Iżykowska
Katarzyna Iżykowska
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
BSBogda Skowrońska
Bogda Skowrońska
JNJerzy Nowak
Jerzy Nowak

Verified
Journal Article
Open access
PDF file
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
MPMarta Podralska
Marta Podralska
MŻMagdalena Żurawek
Magdalena Żurawek
JŁJoanna Łaczmańska
Joanna Łaczmańska
Katarzyna IżykowskaKatarzyna Iżykowska
Katarzyna Iżykowska
NRNatalia Rozwadowska
Natalia Rozwadowska
Hypoxia in non-small cell lung cancer (NSCLC) affects cancer progression, metastasis and metabolism. We previously showed that FAM13A was induced by hypoxia in NSCLC but the biological function of this gene has not been fully elucidated. This study aimed to investigate the role of hypoxia-induced FAM13A in NSCLC progression and metastasis. Lentiviral shRNAs were used for FAM13A gene silencing in NSCLC cell lines (A549, CORL-105). MTS assay, cell tracking VPD540 dye, wound healing assay, invasion assay, BrdU assay and APC Annexin V staining assays were performed to examine cell proliferation ability, migration, invasion and apoptosis rate in NSCLC cells. The results of VPD540 dye and MTS assays showed a significant reduction in cell proliferation after FAM13A knockdown in A549 cells cultured under normal and hypoxia (1% O2) conditions (p < 0.05), while the effect of FAM13A downregulation on CORL-105 cells was observed after 96 h exposition to hypoxia. Moreover, FAM13A inhibition induced S phase cell cycle arrest in A549 cells under hypoxia conditions. Silencing of FAM13A significantly suppressed migration of A549 and CORL-105 cells in both oxygen conditions, especially after 72 and 96 h (p < 0.001 in normoxia, p < 0.01 after hypoxia). It was showed that FAM13A reduction resulted in disruption of the F-actin cytoskeleton altering A549 cell migration. Cell invasion rates were significantly decreased in A549 FAM13A depleted cells compared to controls (p < 0.05), mostly under hypoxia. FAM13A silencing had no effect on apoptosis induction in NSCLC cells. In the present study, we found that FAM13A silencing has a negative effect on proliferation, migration and invasion activity in NSCLC cells in normal and hypoxic conditions. Our data demonstrated that FAM13A depleted post-hypoxic cells have a decreased cell proliferation ability and metastatic potential, which indicates FAM13A as a potential therapeutic target in lung cancer.

20 April 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MPMarta Podralska
Marta Podralska
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
MŻMagdalena Żurawek
Magdalena Żurawek
ADAgnieszka Dzikiewicz-Krawczyk
Agnieszka Dzikiewicz-Krawczyk
RSRyszard Slomski
Ryszard Slomski
MMMaria Mosor
Maria Mosor
DNA damage repair is a complex process, which can trigger the development of cancer if disturbed. In this study, we hypothesize a role of variants in the ATM, H2AFX and MRE11 genes in determining breast cancer (BC) susceptibility. We examined the whole sequence of the ATM kinase domain and estimated the frequency of founder mutations in the ATM gene (c.5932G > T, c.6095G > A, and c.7630-2A > C) and single nucleotide polymorphisms (SNPs) in H2AFX (rs643788, rs8551, rs7759, and rs2509049) and MRE11 (rs1061956 and rs2155209) among 315 breast cancer patients and 515 controls. The analysis was performed using high-resolution melting for new variants and the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method for recurrent ATM mutations. H2AFX and MRE11 polymorphisms were analyzed using TaqMan assays. The cumulative genetic risk scores (CGRS) were calculated using unweighted and weighted approaches. We identified four mutations (c.6067G > A, c.8314G > A, c.8187A > T, and c.6095G > A) in the ATM gene in three BC cases and two control subjects. We observed a statistically significant association of H2AFX variants with BC. Risk alleles (the G of rs7759 and the T of rs8551 and rs2509049) were observed more frequently in BC cases compared to the control group, with P values, odds ratios (OR) and 95% confidence intervals (CIs) of 0.0018, 1.47 (1.19 to 1.82); 0.018, 1.33 (1.09 to 1.64); and 0.024, 1.3 (1.06 to 1.59), respectively. Haplotype-based tests identified a significant association of the H2AFX CACT haplotype with BC (P < 0.0001, OR = 27.29, 95% CI 3.56 to 209.5). The risk of BC increased with the growing number of risk alleles. The OR (95% CI) for carriers of ≥ four risk alleles was 1.71 (1.11 to 2.62) for the CGRS. This study confirms that H2AFX variants are associated with an increased risk of BC. The above-reported sequence variants of MRE11 genes may not constitute a risk factor of breast cancer in the Polish population. The contribution of mutations detected in the ATM gene to the development of breast cancer needs further detailed study.

1 January 2017 in Journal of Cancer
Verified
Journal Article
Open access
IZIwona Ziółkowska-Suchanek
Iwona Ziółkowska-Suchanek
MMMaria Mosor
Maria Mosor
MPMarta Podralska
Marta Podralska
Katarzyna IżykowskaKatarzyna Iżykowska
Katarzyna Iżykowska
Piotr GabryelPiotr Gabryel
Piotr Gabryel
JNJerzy Nowak
Jerzy Nowak
Several genome-wide association studies (GWASs), have identified that FAM13A and IREB2 loci are associated with lung cancer, but the mechanisms by which these genes contribute to lung diseases susceptibility, especially in hypoxia context, are unknown. Hypoxia has been identified as a major negative factor for tumor progression in clinical observation. It has been suggested, that lower oxygen tension, may modulate the IREB2 and FAM13A activity. However, the role of these genes in hypoxia response has not been explained. To precise the role of these genes in hypoxia response, we analyzed the FAM13A and IREB2 expression, in lung cancer cells in vitro and lung cancer tissue fragments cultured ex vivo.